BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

958 related articles for article (PubMed ID: 11389079)

  • 1. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of flow cytometry in the chronic lymphoid leukemias.
    DiGiuseppe JA; Borowitz MJ
    Semin Oncol; 1998 Feb; 25(1):6-10. PubMed ID: 9482521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of some leucocyte differentiation markers and the adenosine deaminase and purine nucleoside phosphorylase values in B and T cell leukemias and lymphomas.
    Mesárosová A; Hrivnáková A; Babusíková O
    Neoplasma; 1995; 42(6):307-12. PubMed ID: 8592572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low level CD20 expression on T cell malignancies.
    Warzynski MJ; Graham DM; Axtell RA; Zakem MH; Rotman RK
    Cytometry; 1994 Jun; 18(2):88-92. PubMed ID: 7523045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD5+ chronic B-cell leukemia with features intermediate to chronic lymphocytic leukemia and hairy cell leukemia.
    Aljurf M; Cornbleet PJ; Michel F
    Hematol Pathol; 1994; 8(3):99-109. PubMed ID: 7527021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cellular immunophenotypes in 97 adults with acute leukemia].
    Piedras J; López-Karpovitch X; Cárdenas MR
    Rev Invest Clin; 1997; 49(6):457-64. PubMed ID: 9528305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic significance of the "lymphoid" CD38 antigen in myeloid blood malignancies.
    Marinov J; Koubek K; Starý J
    Neoplasma; 1993; 40(6):355-8. PubMed ID: 8289967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD24 antigen discriminates between pre-B and B cells in human bone marrow.
    Duperray C; Boiron JM; Boucheix C; Cantaloube JF; Lavabre-Bertrand T; Attal M; Brochier J; Maraninchi D; Bataille R; Klein B
    J Immunol; 1990 Dec; 145(11):3678-83. PubMed ID: 1700990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
    Babusíková O; Glasová M; Stasáková J; Kusenda J; Koníková E
    Neoplasma; 1997; 44(6):348-55. PubMed ID: 9605006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunobiology of chronic lymphocytic leukemia.
    Freedman AS
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):405-29. PubMed ID: 2182599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: relevance for the study of B-cell neoplasias.
    Lavabre-Bertrand T; Duperray C; Brunet C; Poncelet P; Exbrayat C; Bourquard P; Lavabre-Bertrand C; Brochier J; Navarro M; Janossy G
    Leukemia; 1994 Mar; 8(3):402-8. PubMed ID: 8127145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of some cytochemical activities to the expression of CD34 marker in acute leukemia.
    Klobusická M; Babusíková O; Hrivnáková A
    Neoplasma; 1993; 40(5):309-14. PubMed ID: 7505888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
    Rothe G; Schmitz G
    Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of intracellular lymphoid differentiation antigens by flow cytometry in acute lymphoblastic leukemia.
    Sartor M; Bradstock K
    Cytometry; 1994 Sep; 18(3):119-22. PubMed ID: 7813331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
    Babusíková O; Glasová M; Koníková E; Kusenda J
    Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease.
    Drach J; Drach D; Glassl H; Gattringer C; Huber H
    Cytometry; 1992; 13(8):893-901. PubMed ID: 1459006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
    Hurwitz CA; Gore SD; Stone KD; Civin CI
    Leukemia; 1992 Apr; 6(4):233-9. PubMed ID: 1375301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
    al-Katib A; Mohammad RM; Dan M; Hussein ME; Akhtar A; Pettit GR; Sensenbrenner LL
    Exp Hematol; 1993 Jan; 21(1):61-5. PubMed ID: 8093352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.